We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Agilent Introduces OneSeq to Streamline Cytogenetic Research

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Agilent Technologies Inc. has introduced OneSeq, the industry's first all-in-one target enrichment product for next-generation sequencing. OneSeq is designed to detect and analyze copy number variations, loss of heterozygosity, and mutations in a single reaction for use in constitutional disease research.

Agilent is showcasing the new product at the annual Advances in Genome Biology and Technology (AGBT) conference in Marco Island, Florida, this week.

Powered by Agilent's industry-leading SureSelect target-enrichment platform, the new OneSeq constitutional research panel will help laboratories involved in cytogenetic research save time gathering and analyzing complex, multifactorial data.

"OneSeq enables researchers to study both disease-associated targets and copy number variants at the same time," said Alessandro Borsatti, a senior director of marketing at Agilent. "The all-in-one NGS assay-another industry first from the pioneers of target enrichment-provides more information than single molecular techniques, allowing scientists to streamline their workflow."

Borsatti noted that researchers can easily combine OneSeq with Agilent's free-of-charge SureCall software to integrate data analysis of copy number variations, single nucleotide polymorphisms, indels, and loss of heterozygosity.

"This combination offers the most cost-effective and streamlined method of studying multiple DNA changes associated with genetic disorders," Borsatti said. "Whole genome sequencing and its associated data analysis are far more laborious and costly."

In addition, Agilent's online design application, SureDesign, enables researchers to customize OneSeq by adding any gene panel of interest to the CNV backbone to suit their needs.